Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA et al. /ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350.

Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol. 2021;157(8):940–6.

Article  PubMed  Google Scholar 

Egeberg A, Skov L, Joshi AA, Mallbris L, Gislason GH, Wu JJ, et al. The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events. J Am Acad Dermatol. 2017;77(4):650–6e3.

Article  PubMed  PubMed Central  Google Scholar 

Teklu M, Zhou W, Kapoor P, Patel N, Dey AK, Sorokin AV, et al. Metabolic syndrome and its factors are associated with noncalcified coronary burden in psoriasis: an observational cohort study. J Am Acad Dermatol. 2021;84(5):1329–38.

Article  CAS  PubMed  Google Scholar 

Mehta NN, Li R, Krishnamoorthy P, Yu Y, Farver W, Rodrigues A, et al. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis. 2012;224(1):218–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akkara Veetil BM, Matteson EL, Maradit-Kremers H, McEvoy MT, Crowson CS. Trends in lipid profiles in patients with psoriasis: a population-based analysis. BMC Dermatol. 2012;12:20.

Article  PubMed  PubMed Central  Google Scholar 

Mallbris L, Granath F, Hamsten A, Ståhle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54(4):614–21.

Article  PubMed  Google Scholar 

Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, et al. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet. 2010;376(9738):333–9.

Article  CAS  PubMed  Google Scholar 

Krauss RM. Dense low density lipoproteins and coronary artery disease. Am J Cardiol. 1995;75(6):53b–7b.

Article  CAS  PubMed  Google Scholar 

Frazier-Wood AC, Manichaikul A, Aslibekyan S, Borecki IB, Goff DC, Hopkins PN, et al. Genetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicity. Hum Genet. 2013;132(4):405–13.

Article  CAS  PubMed  Google Scholar 

Tsai MY, Steffen BT, Guan W, McClelland RL, Warnick R, McConnell J, et al. New automated assay of small dense low-density lipoprotein cholesterol identifies risk of coronary heart disease: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(1):196–201.

Article  CAS  PubMed  Google Scholar 

Schulte DM, Paulsen K, Türk K, Brandt B, Freitag-Wolf S, Hagen I, et al. Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases. Nutr Metab Cardiovasc Dis. 2018;28(11):1100–5.

Article  CAS  PubMed  Google Scholar 

Hoogeveen RC, Gaubatz JW, Sun W, Dodge RC, Crosby JR, Jiang J, et al. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014;34(5):1069–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, et al. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study. Cardiovasc Diabetol. 2020;19(1):45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan J, Liu Y, Yin S, Chen N, Bai X, Ke Q, et al. Small dense LDL cholesterol is associated with metabolic syndrome traits independently of obesity and inflammation. Nutr Metab (Lond). 2019;16:7.

Article  PubMed  Google Scholar 

Ohmura H, Mokuno H, Sawano M, Hatsumi C, Mitsugi Y, Watanabe Y, et al. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism. 2002;51(9):1081–7.

Article  CAS  PubMed  Google Scholar 

Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Wiklund O, Bondjers G. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res. 1990;31(8):1387–98.

Article  CAS  PubMed  Google Scholar 

Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, et al. Association between Oxidation-Modified lipoproteins and coronary plaque in Psoriasis. Circ Res. 2018;123(11):1244–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Izumida T, Nakamura Y, Hino Y, Ishikawa S. Combined effect of small dense low-density lipoprotein cholesterol (sdLDL-C) and Remnant-Like particle cholesterol (RLP-C) on Low-Grade inflammation. J Atheroscler Thromb. 2020;27(4):319–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsu SH, Jang MH, Torng PL, Su TC. Positive Association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation, thrombosis, and Prediabetes in non-diabetic adults. J Atheroscler Thromb. 2019;26(7):624–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duran EK, Aday AW, Cook NR, Buring JE, Ridker PM, Pradhan AD. Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and Incident Cardiovascular Disease. J Am Coll Cardiol. 2020;75(17):2122–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brunzell JD, Zambon A, Deeb SS. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim Biophys Acta. 2012;1821(3):365–72.

Article  CAS  PubMed  Google Scholar 

Sampson M, Wolska A, Warnick R, Lucero D, Remaley AT. A new equation based on the standard lipid panel for calculating small dense low-density lipoprotein-cholesterol and its use as a risk-enhancer test. Clin Chem. 2021;67(7):987–97.

Article  PubMed  PubMed Central  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7.

Article  Google Scholar 

Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, et al. Coronary artery Disease - Reporting and Data System (CAD-RADS): an Expert Consensus Document of SCCT, ACR and NASCI: endorsed by the ACC. JACC Cardiovasc Imaging. 2016;9(9):1099–113.

Article  PubMed  Google Scholar 

Salahuddin T, Natarajan B, Playford MP, Joshi AA, Teague H, Masmoudi Y, et al. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. Eur Heart J. 2015;36(39):2662–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.

Article  CAS  PubMed  Google Scholar 

Palmer MK, Barter PJ, Lundman P, Nicholls SJ, Toth PP, Karlson BW. Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: a VOYAGER analysis. Clin Biochem. 2019;64:24–9.

Article  CAS  PubMed  Google Scholar 

Sampson M, Ling C, Sun Q, Harb R, Ashmaig M, Warnick R, et al. A New equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and/or hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540–8.

Article  PubMed  Google Scholar 

Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular Risk in patients with psoriasis: JACC Review topic of the Week. J Am Coll Cardiol. 2021;77(13):1670–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan MT, Shin DB, Hubbard RA, Noe MH, Mehta NN, Gelfand JM. Psoriasis and the risk of diabetes: a prospective population-based cohort study. J Am Acad Dermatol. 2018;78(2):315–22e1.

Article  PubMed  Google Scholar 

Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi HK. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003–2006. Arch Dermatol. 2011;147(4):419–24.

Article  PubMed  Google Scholar 

Guérin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes: impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol. 2001;21(2):282–8.

Article  PubMed  Google Scholar 

Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans. 2003;31(Pt 5):1066–9.

Article  CAS  PubMed  Google Scholar 

Choi H, Uceda DE, Dey AK, Abdelrahman KM, Aksentijevich M, Rodante JA, et al. Treatment of Psoriasis with Biologic Therapy is Associated with improvement of coronary artery plaque lipid-rich necrotic core: results from a prospective, observational study. Circ Cardiovasc Imaging. 2020;13(9):e011199.

Article  PubMed